Should You Buy Moderna Before Feb. 13?
(NASDAQ: MRNA) has been on fire this year, with the biotech's shares up by 39% through Feb. 6. This isn't due to the company's financial results. Moderna has yet to release its fourth-quarter 2025 update. That's coming up on Feb. 13.
And although it provided guidance for 2025, that was months ago and wasn't nearly spectacular enough to jolt the stock this much. What's driving Moderna's performance in 2026? And should investors buy the stock before its next quarterly update? Let's take a look.
Image source: Getty Images.
Source Fool.com
Moderna Inc. Stock
€34.29
0.500%
Currently there is a rather negative sentiment for Moderna Inc. with 6 Buy predictions and 9 Sell predictions..
This results in a negative potential of -38.75% based on a current price of 34.29 € and a target price of 21 € for the stock.
